Incyte INCY
NASDAQ INCY
$122.27 +1.97 (+1.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Incyte (INCY) Gains from Sales and Divestitures (2016 - 2026)

Updated

Analysis

Incyte (INCY) Gains from Sales and Divestitures (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Incyte 245.42 Mn -15.74 Bn 1.45 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 649,000.00
Jun 30, 2026 -1.63 Mn
Mar 31, 2026 1.63 Mn
Dec 31, 2025 771,000.00
Sep 30, 2025 112,000.00
Jun 30, 2025 1.16 Mn
Mar 31, 2025 2.89 Mn
Dec 31, 2024 -941,000.00
Sep 30, 2024 2.74 Mn
Jun 30, 2024 417,000.00
Mar 31, 2024 383,000.00
Dec 31, 2023 5.04 Mn
Sep 30, 2023 -4.41 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 3.06 Mn
Dec 31, 2022 -5.34 Mn
Sep 30, 2022 -116,000.00
Jun 30, 2022 -6.81 Mn
Mar 31, 2022 15.76 Mn
Dec 31, 2021 3.21 Mn
API Access

Incyte Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=INCY&period=max&api_key=YOUR_API_KEY